GO ID | Source | Type | Description |
GO:0002080 |
IEA:Ensembl | C | acrosomal membrane |
GO:0016324 |
IEA:Ensembl | C | apical plasma membrane |
GO:0016323 |
IEA:Ensembl | C | basolateral plasma membrane |
GO:0005901 |
IEA:UniProtKB-SubCell | C | caveola |
GO:0005938 |
IEA:Ensembl | C | cell cortex |
GO:0005929 |
IEA:Ensembl | C | cilium |
GO:0005783 |
IEA:Ensembl | C | endoplasmic reticulum |
GO:0005768 |
IEA:Ensembl | C | endosome |
GO:0000139 |
IEA:UniProtKB-SubCell | C | Golgi membrane |
GO:0005887 |
IEA:Ensembl | C | integral component of plasma membrane |
GO:0048471 |
IEA:Ensembl | C | perinuclear region of cytoplasm |
GO:0043234 |
IEA:Ensembl | C | protein complex |
GO:0016504 |
IEA:Ensembl | F | peptidase activator activity |
GO:0005198 |
IEA:Ensembl | F | structural molecule activity |
GO:0001525 |
IEA:Ensembl | P | angiogenesis |
GO:0097190 |
IEA:Ensembl | P | apoptotic signaling pathway |
GO:0006816 |
IEA:Ensembl | P | calcium ion transport |
GO:0070836 |
IEA:Ensembl | P | caveola assembly |
GO:0072584 |
IEA:Ensembl | P | caveolin-mediated endocytosis |
GO:0071455 |
IEA:Ensembl | P | cellular response to hyperoxia |
GO:0009267 |
IEA:Ensembl | P | cellular response to starvation |
GO:0042632 |
IEA:Ensembl | P | cholesterol homeostasis |
GO:0051480 |
IEA:Ensembl | P | cytosolic calcium ion homeostasis |
GO:0000188 |
IEA:Ensembl | P | inactivation of MAPK activity |
GO:0007595 |
IEA:Ensembl | P | lactation |
GO:0019915 |
IEA:Ensembl | P | lipid storage |
GO:0060056 |
IEA:Ensembl | P | mammary gland involution |
GO:0000165 |
IEA:Ensembl | P | MAPK cascade |
GO:0051899 |
IEA:Ensembl | P | membrane depolarization |
GO:2000811 |
IEA:Ensembl | P | negative regulation of anoikis |
GO:0030514 |
IEA:Ensembl | P | negative regulation of BMP signaling pathway |
GO:0090090 |
IEA:Ensembl | P | negative regulation of canonical Wnt signaling pathway |
GO:0001960 |
IEA:Ensembl | P | negative regulation of cytokine-mediated signaling pathway |
GO:0001937 |
IEA:Ensembl | P | negative regulation of endothelial cell proliferation |
GO:0030857 |
IEA:Ensembl | P | negative regulation of epithelial cell differentiation |
GO:0045019 |
IEA:Ensembl | P | negative regulation of nitric oxide biosynthetic process |
GO:0051001 |
IEA:Ensembl | P | negative regulation of nitric-oxide synthase activity |
GO:0033137 |
IEA:Ensembl | P | negative regulation of peptidyl-serine phosphorylation |
GO:0048550 |
IEA:Ensembl | P | negative regulation of pinocytosis |
GO:0032091 |
IEA:Ensembl | P | negative regulation of protein binding |
GO:0031397 |
IEA:Ensembl | P | negative regulation of protein ubiquitination |
GO:0000122 |
IEA:Ensembl | P | negative regulation of transcription from RNA polymerase II promoter |
GO:0042524 |
IEA:Ensembl | P | negative regulation of tyrosine phosphorylation of Stat5 protein |
GO:0033484 |
IEA:Ensembl | P | nitric oxide homeostasis |
GO:0010524 |
IEA:Ensembl | P | positive regulation of calcium ion transport into cytosol |
GO:0090263 |
IEA:Ensembl | P | positive regulation of canonical Wnt signaling pathway |
GO:2001238 |
IEA:Ensembl | P | positive regulation of extrinsic apoptotic signaling pathway |
GO:2001244 |
IEA:Ensembl | P | positive regulation of intrinsic apoptotic signaling pathway |
GO:0048554 |
IEA:Ensembl | P | positive regulation of metalloenzyme activity |
GO:0033138 |
IEA:Ensembl | P | positive regulation of peptidyl-serine phosphorylation |
GO:0045907 |
IEA:Ensembl | P | positive regulation of vasoconstriction |
GO:0051260 |
IEA:Ensembl | P | protein homooligomerization |
GO:0008104 |
IEA:Ensembl | P | protein localization |
GO:2000286 |
IEA:Ensembl | P | receptor internalization involved in canonical Wnt signaling pathway |
GO:0030193 |
IEA:Ensembl | P | regulation of blood coagulation |
GO:0019217 |
IEA:Ensembl | P | regulation of fatty acid metabolic process |
GO:0006940 |
IEA:Ensembl | P | regulation of smooth muscle contraction |
GO:0003057 |
IEA:Ensembl | P | regulation of the force of heart contraction by chemical signal |
GO:0051592 |
IEA:Ensembl | P | response to calcium ion |
GO:0043627 |
IEA:Ensembl | P | response to estrogen |
GO:0001666 |
IEA:Ensembl | P | response to hypoxia |
GO:0002931 |
IEA:Ensembl | P | response to ischemia |
GO:0032570 |
IEA:Ensembl | P | response to progesterone |
GO:0007519 |
IEA:Ensembl | P | skeletal muscle tissue development |
GO:0031295 |
IEA:Ensembl | P | T cell costimulation |
GO:0006641 |
IEA:Ensembl | P | triglyceride metabolic process |
GO:0001570 |
IEA:Ensembl | P | vasculogenesis |
GO:0042310 |
IEA:Ensembl | P | vasoconstriction |
GO:0016050 |
IEA:Ensembl | P | vesicle organization |
REACTOME Pathway ID | Description |
---|
5954052 | Basigin interactions |
5953650 | Cell surface interactions at the vascular wall |
5954029 | disassembly of the destruction complex and recruitment of AXIN to the membrane |
5953253 | Disease |
5954032 | eNOS activation |
5954033 | eNOS activation and regulation |
5953645 | Hemostasis |
5953753 | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
5953754 | Lipid digestion, mobilization, and transport |
5953250 | Metabolism |
5953289 | Metabolism of lipids and lipoproteins |
5954034 | Metabolism of nitric oxide |
5954026 | misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling |
5954043 | NOSTRIN mediated eNOS trafficking |
5954027 | RNF mutants show enhanced WNT signaling and proliferation |
5953420 | Signaling by VEGF |
5953803 | Signaling by Wnt |
5953965 | Signaling by WNT in cancer |
5953381 | Signal Transduction |
5954025 | TCF dependent signaling in response to WNT |
5953419 | VEGFA-VEGFR2 Pathway |
5953999 | VEGFR2 mediated vascular permeability |
5954028 | XAV939 inhibits tankyrase, stabilizing AXIN |